Search
Search Funnelback University
- Refined by:
- Date: 2022
151 -
200 of
230
search results for `news stories`
Fully-matching results
-
Anti Herpes Simplex Virus Glycoprotein D AP12 (anti-HSV gD)
https://www.enterprise.cam.ac.uk/reagents/herpes-simplex-virus-glycoprotein-d-monoclonal-antibody-ap12-anti-hsv-gd/9 May 2022: Hybridoma cell line producing AP12 antibodies against Herpes Simplex Virus Type-1 and Type-2 envelope protein Glycoprotein D, which are of the IgG1 isotype. -
https://www.spri.cam.ac.uk/museum/news/education/feed/
https://www.spri.cam.ac.uk/museum/news/education/feed/19 May 2022: Education – The Polar Museum: news blog https://www.spri.cam.ac.uk/museum/news News from the Scott Polar Research Institute Museum Fri, 28 Jan 2022 18:07:08 0000 ... text"Welcoming back the student curators/p/div pThe exhibition is all about climate -
Anti Herpes Simplex Virus Glycoprotein D LP14 (anti-HSV gD)
https://www.enterprise.cam.ac.uk/reagents/herpes-simplex-virus-glycoprotein-d-monoclonal-antibody-lp14-anti-hsv-gd/9 May 2022: Hybridoma cell line producing LP14 antibodies against Herpes Simplex Virus Type-1 and Type-2 envelope protein Glycoprotein D which are of the IgG2a isotype. -
Apollo Therapeutics: Pioneering collaboration launches its next phase …
https://www.enterprise.cam.ac.uk/case-studies/apollo-therapeutics-pioneering-collaboration-launches-its-next-phase/11 Apr 2022: Apollo Therapeutics was launched as a £100 million biopharmaceutical company in June 2021. -
KARPAS 299 Human Non-Hodgkin's Ki-positive Lymphoma
https://www.enterprise.cam.ac.uk/reagents/karpas-299-human-non-hodgkins-ki-positive-large-cell-lymphoma-cell-line/9 May 2022: KARPAS 299 Human Non-Hodgkin's Ki-positive Large Cell Lymphoma cell line useful in oncology research, developed at the University of Cambridge. -
Can commercialisation lead to better impact outcomes for policy…
https://www.enterprise.cam.ac.uk/can-commercialisation-lead-to-better-impact-outcomes-for-policy-research/16 Dec 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 16 December 2022. Can commercialisation lead to better impact outcomes for policy research? Share:. We asked our participants whether a research commercialisation approach or -
Anti Herpes Simplex Virus Type 1 Glycoprotein B CB24
https://www.enterprise.cam.ac.uk/reagents/herpes-simplex-virus-type-1-hsv-1-glycoprotein-b-monoclonal-antibody-cb24/9 May 2022: Hybridoma cell line producing CB24 monoclonal antibodies raised against Herpes Simplex Virus Type-1 envelope protein Glycoprotein B, of the IgG2b isotype. -
Herpes Simplex Virus Type 1 Glycoprotein H antibody BBH1
https://www.enterprise.cam.ac.uk/reagents/herpes-simplex-virus-type-1-hsv-1-glycoprotein-h-monoclonal-antibody-bbh1/9 May 2022: Hybridoma cell line producing BBH1 monoclonal antibodies raised against Herpes Simplex Virus Type-1 envelope protein Glycoprotein H, of the IgG2a isotype. -
The University of Cambridge ecosystem – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/about/our-role-within-the-cambridge-ecosystem/within-the-university/20 Jul 2022: We work closely with University members to help them create impact from their research through knowledge and technology transfer. -
Cambridge GaN Devices case study – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/cambridge-gan-devices-reshaping-power-electronics-for-a-greener-future/11 Apr 2022: investment. Less than five years later, we again released news about the company. ... This time, however, the news was the completion of a $9.5 million Series A funding round. -
ICM+ software for brain monitoring in neurological intensive care…
https://www.enterprise.cam.ac.uk/reagents/icm-software-for-brain-monitoring-in-neurological-intensive-care-research/9 May 2022: ICM+ software provides real-time multimodality monitoring, analysis and data storage in neurological intensive care environments. -
A consultant's miscellany: Hugh Hunt's many consultancy…
https://www.enterprise.cam.ac.uk/case-studies/consultants-miscellany-hugh-hunts-many-varied-consultancy-projects/22 Mar 2022: When Cambridge Enterprise was looking to make a film about Consultancy Services, Dr Hugh Hunt, Cambridge University Reader in Engineering Dynamics and... -
Anti Human Insulin-like growth factor-1 receptor IGF 1R 1-2
https://www.enterprise.cam.ac.uk/reagents/human-insulin-like-growth-factor-1-receptor-monoclonal-antibody-igf-1r-1-2/9 May 2022: Hybridoma cell line producing IGF-1R 1-2 antibodies raised against the extreme C-terminus of the human insulin-like growth factor receptor beta subunit. -
Herpes Simplex Virus Type 1 (HSV-1) VP21/VP22a antibody
https://www.enterprise.cam.ac.uk/reagents/herpes-simplex-virus-type-1-hsv-1-vp21vp22a-scaffold-monoclonal-antibody-lp13/9 May 2022: Hybridoma cell line producing LP13 antibodies raised against Herpes Simplex Virus Type-1 VP21/VP22a scaffold protein, mouse monoclonals of IgG2a isotype. -
Anti Human insulin-like growth factor-1 receptor IGF-1R 26-3
https://www.enterprise.cam.ac.uk/reagents/human-insulin-like-growth-factor-1-receptor-monoclonal-antibody-igf-1r-26-3/9 May 2022: Hybridoma cell line producing IGF-1R 26-3 antibodies against human insulin-like growth factor receptor (epitope 283-440 or 586-908) and of the IgG1 isotype. -
EVALUATING GOOGLE TRENDS AS A PRIMARY CARE RESEARCH TOOL
https://www.phpc.cam.ac.uk/pcu/files/2022/05/Maisie-Fitzgerald-Evaluating-Google-Trends.pdf3 May 2022: for by news stories into the first reported death from vaping at the time19. ... vaping, is implicated by interest in news stories about the health behaviour in question. -
Anti Human insulin-like growth factor-1 receptor IGF-1R 24-57
https://www.enterprise.cam.ac.uk/reagents/human-insulin-like-growth-factor-1-receptor-monoclonal-antibody-igf-1r-24-57/9 May 2022: Hybridoma cell line producing IGF-1R 24-57 antibodies raised against the human insulin-like growth factor receptor, which are of the IgG1 isotype. -
Anti Human insulin-like growth factor-1 receptor IGF-1R 24-55
https://www.enterprise.cam.ac.uk/reagents/human-insulin-like-growth-factor-1-receptor-monoclonal-antibody-igf-1r-24-55/9 May 2022: Hybridoma cell line producing IGF-1R 24-55 antibodies against the human insulin-like growth factor receptor (epitope 440-586) which are of the IgG1 isotype. -
Anti Human insulin-like growth factor-1 receptor IGF-1R 17-69
https://www.enterprise.cam.ac.uk/reagents/human-insulin-like-growth-factor-1-receptor-monoclonal-antibody-igf-1r-17-69/9 May 2022: Hybridoma cell line producing IGF-1R 17-69 antibodies against the human insulin-like growth factor receptor (epitope 440-586) which are of the IgG1 isotype. -
Anti Human insulin-like growth factor 1 receptor IGF-1R 24-31
https://www.enterprise.cam.ac.uk/reagents/human-insulin-like-growth-factor-1-receptor-monoclonal-antibody-igf-1r-24-31/9 May 2022: Hybridoma cell line producing IGF-1R 24-31 antibodies against human insulin-like growth factor 1 receptor (283-440 or 586-908 epitope). -
Anti Human insulin-like growth factor-1 receptor IGF-1R 24-60
https://www.enterprise.cam.ac.uk/reagents/human-insulin-like-growth-factor-1-receptor-monoclonal-antibody-igf-1r-24-60/9 May 2022: Hybridoma cell line producing IGF-1R 24-60 antibodies against the human insulin-like growth factor receptor (epitope 184-283), which are the IgG2a isotype. -
Science and Technology Facilities Council (STFC) Knowledge Exchange…
https://www.enterprise.cam.ac.uk/grant/science-and-technology-facilities-council-stfc-knowledge-exchange-and-commercialisation-kec-fellowships/18 Jan 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Science and Technology Facilities Council (STFC) Knowledge Exchange and Commercialisation (KEC) Fellowships. The KEC Fellowship scheme is designed to facilitate the development of -
Cambridge spin-out secures $3.4m to invent the way humanity interacts …
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-secures-3-4m-to-invent-the-way-humanity-interacts-with-a-i/23 Mar 2022: Tenyks, a University of Cambridge spin-out focused on helping machine learning engineers build better, safer artificial intelligence, has raised a $3.4 million seed round. -
Cambridge spin-out raises $6m seed round for transformative…
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-raises-6m-seed-round-for-transformative-regulatory-data-structures/12 Apr 2022: University of Cambridge spin-out RegGenome announces the completion of a $6 million seed funding round. -
Consultancy services case study – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/consultancy-services-a-university-lab-tests-anti-viral-materials-for-companies/11 Apr 2022: Our consultancy services team supported Department of Chemical Engineering and Biotechnology researchers in testing anti-viral materials. -
Realising the market potential of software – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/realising-the-market-potential-of-software/18 Jul 2022: Related news and case studies. Pause. Play. Review our answers to your most frequently asked questions. -
PowerPoint Presentation
https://www.cisl.cam.ac.uk/files/cop15_roundup.pdf19 Dec 2022: COP15Roundup. COP15RoundupWeek 1. • Representatives from around 190 countries kicked off COP15 in Montreal, Canada with the aim of reaching a “post-2020 Global Biodiversity Framework”. • Speaking at the press conference of COP15, United -
3C Programme: Supporting the development of innovation ecosystems in…
https://www.enterprise.cam.ac.uk/case-studies/3c-programme-supporting-the-development-of-innovation-ecosystems-in-argentina/11 Apr 2022: Cambridge Enterprise is collaborating with 3C Programme, an international consortium supporting the development of technology innovation ecosystems in Argentina. -
GreenSwirl software for calculating Green's function for swirling …
https://www.enterprise.cam.ac.uk/reagents/greenswirl-software-for-calculating-greens-function-for-swirling-flow-in-an-infinite-duct/9 May 2022: GreenSwirl is a MATLAB programme to calculate the Green's function for swirling flow in an infinite duct. -
Message from Professor Gilbert The “new normal” seems to ...
https://radiology.medschl.cam.ac.uk/wp-content/uploads/2022/04/Newsletter2020Q3-Final.pdf5 Apr 2022: https://www.ourcambridge.admin.cam.ac.uk/news/more-staff-tell-their-lockdown-learnings-video-stories. Department News. 2020 ISMRM & SMRT Virtual Meeting Review. The 2020 ISMRM & SMRT Conference & Exhibition was ... latest news and upcoming events and any -
petermr's blog | A Scientist and the Web | Page 188
https://blogs.ch.cam.ac.uk/pmr/page/188/17 Jan 2022: Carbon-Based Curiosities — Live with Regis and Kelly — A healthy balance of research news and assorted fluff, although Excimer swears more than Regis. ... news, lab research, and human interest stories. -
Cambridge spin-out enters $42m partnership to develop…
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-enters-42m-partnership-to-develop-future-proofed-coronavirus-vaccines/8 Mar 2022: Cambridge spin-out DIOSynVax will receive $42 million to develop a vaccine candidate to protect against existing and future variants of SARS-CoV-2. -
Centessa Pharmaceuticals – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/centessa-pharmaceuticals-three-portfolio-companies-merge-into-a-new-pharmaceutical-giant/11 Apr 2022: Centessa Pharmaceuticals, which launched with $250 million in Series A financing, acquired three Cambridge Enterprise portfolio companies. -
Anti Herpes Simplex Virus Type 2 Glycoprotein C LP6
https://www.enterprise.cam.ac.uk/reagents/herpes-simplex-virus-type-2-hsv-2-glycoprotein-c-monoclonal-antibody-lp6-anti-hsv-gc/9 May 2022: Hybridoma cell line producing LP6 antibodies raised against Herpes Simplex Virus Type-2 envelope protein Glycoprotein C, which are of the IgG2a isotype. -
Anti Herpes Simplex Virus Type 2 Glycoprotein E AP10
https://www.enterprise.cam.ac.uk/reagents/herpes-simplex-virus-type-2-hsv-2-glycoprotein-e-monoclonal-antibody-ap10-anti-hsv-ge/9 May 2022: Hybridoma cell line producing AP10 antibodies raised against Herpes Simplex Virus Type-2 envelope protein Glycoprotein E, which are of the IgG2a isotype. -
Anti Herpes Simplex Virus Type 1 Glycoprotein G LP10
https://www.enterprise.cam.ac.uk/reagents/herpes-simplex-virus-type-1-hsv-1-glycoprotein-g-monoclonal-antibody-lp10-anti-hsv-gg/9 May 2022: Hybridoma cell line producing LP10 antibodies raised against Herpes Simplex Virus Type-1 envelope protein Glycoprotein G, which are of the IgG3 isotype. -
Herpes Simplex Virus Type 2 Glycoprotein G monoclonal AP1
https://www.enterprise.cam.ac.uk/reagents/herpes-simplex-virus-type-2-hsv-2-glycoprotein-g-monoclonal-antibody-ap1-anti-hsv-gg/9 May 2022: Hybridoma cell line producing AP1 antibodies raised against Herpes Simplex Virus Type-2 envelope protein Glycoprotein G, which are of the IgG2a isotype. -
Versed AI case study – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/versed-ai-harnessing-artificial-intelligence-to-reveal-hidden-supply-chain-risks/11 Apr 2022: Mining millions of words in news articles, business reports, and social media posts, Versed AI’s technology maps out multi-tier supply chains, revealing patterns and shining light on missing links. -
BKwai raises £2.2m seed round – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/cambridge-joins-2-2m-seed-round-for-data-driven-infrastructure-and-construction-platform/8 Mar 2022: Cambridge Enterprise joins £2.2 million seed round for construction data company BKwai, helping develop smarter, more sustainable infrastructure. -
Challenges and Opportunities for Commercialisation of Research out of …
https://www.enterprise.cam.ac.uk/challenges-and-opportunities-for-commercialisation-of-research-out-of-the-social-sciences/25 Oct 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 26 October 2022. Challenges and Opportunities for Commercialisation of Research out of the Social Sciences. Share:. I was delighted to join Cambridge Enterprise as a Project Associate -
Data are part of the future; the OKFN’s contribution | petermr's…
https://blogs.ch.cam.ac.uk/pmr/2012/05/08/data-are-part-of-the-future-the-okfns-contribution/17 Jan 2022: Data Wrangler. We’re looking for a data wrangler who is excited to tell stories through data. ... Our day-to-day work has many facets. We work on the core platform, undertake journalistic projects as part of “Spending Stories”, which won the Knight -
Cambridge Enterprise joins in £18m Series B to speed adoption of…
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-joins-in-18m-series-b-to-accelerate-adoption-of-sustainable-textile-dyeing-solution/31 May 2022: Cambridge Enterprise joins H&M in an £18 million Series B investment round for portfolio company Colorifix -
The journey of a University idea – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/the-journey-of-a-university-idea/10 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. The journey of a University idea. How to make your commercial idea thrive. You have come up with an exciting commercial idea – but what do you do next? The diagram below gives an -
petermr's blog | A Scientist and the Web | Page 98
https://blogs.ch.cam.ac.uk/pmr/page/98/17 Jan 2022: Expert articles, personal stories, blogs, Q&A, news, local resources, pictures, video and a supportive community. -
Cambridge Enterprise co-leads £2.4m investment in spin-out developing …
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-co-leads-2-4m-investment-in-spin-out-developing-adc-cancer-therapeutics/14 Jun 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 14 June 2022. Cambridge Enterprise co-leads £2.4m investment in spin-out developing ADC cancer therapeutics. Share:. Spirea Limited, a University of Cambridge spin-out company created -
petermr's blog | A Scientist and the Web | Page 45
https://blogs.ch.cam.ac.uk/pmr/page/45/17 Jan 2022: Data Wrangler. We’re looking for a data wrangler who is excited to tell stories through data. ... Our day-to-day work has many facets. We work on the core platform, undertake journalistic projects as part of “Spending Stories”, which won the Knight -
Anti Herpes Simplex Virus Type 1 and 2 Major Capsid antigen (VP5)
https://www.enterprise.cam.ac.uk/reagents/herpes-simplex-virus-type-1-and-2-hsv-1-and-2-major-capsid-antigen-vp5-monoclonal-antibody-lp12-anti-hsv-vp5/9 May 2022: Hybridoma cell line producing LP12 antibodies raised against Herpes Simplex Virus Type-1 and 2 Major Capsid antigen (VP5), which are of the IgG2a isotype. -
Joint Harvard-Cambridge spin-out closes $50m Series A to drive…
https://www.enterprise.cam.ac.uk/news/joint-harvard-cambridge-spin-out-closes-50m-series-a-to-drive-biomolecular-condensate-drug-discovery/4 Jul 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 6 June 2022. Joint Harvard-Cambridge spin-out closes $50m Series A to drive biomolecular condensate drug discovery. Share:. a joint spin-out from the University of Cambridge and Havard -
Cambridge Enterprise, Cambridge Innovation Capital, and University…
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-cambridge-innovation-capital-and-the-university-of-cambridge-launch-ambitious-innovate-cambridge-initiative/20 Sep 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 20 September 2022. Cambridge Enterprise, Cambridge Innovation Capital, and University launch Innovate Cambridge. Share:. Cambridge Enterprise, Cambridge Innovation Capital, and the -
Cambridge spin-out raises £4.2m to tackle gigatonnes of emissions…
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-raises-4-2m-to-tackle-gigatonnes-of-emissions-from-highly-pollutive-cement-industry/8 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 7 November 2022. Cambridge spin-out raises £4.2m to tackle gigatonnes of emissions from highly pollutive cement industry. Share:. University of Cambridge and UCL joint spin-out to
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.